AtriCure offers surgical devices for ablating cardiac tissue with either cryothermia or bipolar radiofrequency energy.
Hybrid AF Convergent Therapy combines minimally invasive epicardial and endocardial ablation for the treatment of long-standing persistent atrial fibrillation.
AtriCure offers an epicardial access device designed to reduce risks associated with standard epicardial access techniques.
Hybrid Total Thoracoscopic Therapy is a minimally invasive epicardial ablation procedure.
AtriCure’s AtriClip Left Atrial Appendage Exclusion System Products are the most widely implanted LAA devices worldwide.
Cryo Nerve Block Therapy for post-operative pain management in patients undergoing cardiothoracic or chest wall surgery.
These surgical instruments provide complete solutions with optimal exposure and unmatched instrumentation for valve procedures using minimally invasive access.
PM-US-1252E-1226-G
© 2025 Atricure, Inc. All Rights Reserved.
